[DPHARMA] YoY Annual (Unaudited) Result on 31-Dec-2014 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
YoY- 9.28%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 467,987 312,940 270,680 176,961 162,405 135,310 138,132 22.53%
PBT 51,796 31,479 49,755 46,509 40,175 35,298 34,728 6.88%
Tax -9,696 -4,653 0 0 -7,900 -9,284 -8,023 3.20%
NP 42,100 26,826 49,755 46,509 32,275 26,014 26,705 7.87%
-
NP to SH 42,492 27,115 38,775 35,271 32,275 26,014 26,705 8.04%
-
Tax Rate 18.72% 14.78% 0.00% 0.00% 19.66% 26.30% 23.10% -
Total Cost 425,887 286,114 220,925 130,452 130,130 109,296 111,427 25.01%
-
Net Worth 479,809 454,703 270,177 192,942 181,850 169,354 163,783 19.59%
Dividend
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Div 23,711 18,132 15,843 25,679 24,293 19,434 24,983 -0.86%
Div Payout % 55.80% 66.87% 40.86% 72.81% 75.27% 74.71% 93.56% -
Equity
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Net Worth 479,809 454,703 270,177 192,942 181,850 169,354 163,783 19.59%
NOSH 278,959 278,959 278,959 138,807 138,817 138,815 138,799 12.32%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 9.00% 8.57% 18.38% 26.28% 19.87% 19.23% 19.33% -
ROE 8.86% 5.96% 14.35% 18.28% 17.75% 15.36% 16.31% -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 167.76 112.18 162.30 127.49 116.99 97.47 99.52 9.08%
EPS 15.09 9.62 19.17 25.41 23.25 18.74 19.24 -3.96%
DPS 8.50 6.50 9.50 18.50 17.50 14.00 18.00 -11.74%
NAPS 1.72 1.63 1.62 1.39 1.31 1.22 1.18 6.47%
Adjusted Per Share Value based on latest NOSH - 138,813
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 48.65 32.53 28.14 18.40 16.88 14.07 14.36 22.52%
EPS 4.42 2.82 4.03 3.67 3.36 2.70 2.78 8.02%
DPS 2.46 1.88 1.65 2.67 2.53 2.02 2.60 -0.91%
NAPS 0.4988 0.4727 0.2809 0.2006 0.189 0.1761 0.1703 19.59%
Price Multiplier on Financial Quarter End Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 -
Price 2.53 1.98 2.62 2.50 2.58 2.13 2.02 -
P/RPS 1.51 1.76 1.61 1.96 2.21 2.19 2.03 -4.80%
P/EPS 16.61 20.37 11.27 9.84 11.10 11.37 10.50 7.93%
EY 6.02 4.91 8.87 10.16 9.01 8.80 9.52 -7.34%
DY 3.36 3.28 3.63 7.40 6.78 6.57 8.91 -14.98%
P/NAPS 1.47 1.21 1.62 1.80 1.97 1.75 1.71 -2.48%
Price Multiplier on Announcement Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 28/02/18 24/02/17 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 -
Price 2.97 2.23 2.61 2.92 2.60 2.17 2.12 -
P/RPS 1.77 1.99 1.61 2.29 2.22 2.23 2.13 -3.03%
P/EPS 19.50 22.94 11.23 11.49 11.18 11.58 11.02 9.96%
EY 5.13 4.36 8.91 8.70 8.94 8.64 9.08 -9.06%
DY 2.86 2.91 3.64 6.34 6.73 6.45 8.49 -16.57%
P/NAPS 1.73 1.37 1.61 2.10 1.98 1.78 1.80 -0.65%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment